These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 19058005)
1. Does the expression of cyclin E, pRb, and p21 correlate with prognosis in gastric adenocarcinoma? Kouraklis G; Katsoulis IE; Theocharis S; Tsourouflis G; Xipolitas N; Glinavou A; Sioka C; Kostakis A Dig Dis Sci; 2009 May; 54(5):1015-20. PubMed ID: 19058005 [TBL] [Abstract][Full Text] [Related]
2. The Prognostic Value of G1 Cyclins, p21 and Rb Protein in Patients With Colon Cancer. Palaiologos P; Chrysikos D; Theocharis S; Kouraklis G Anticancer Res; 2019 Nov; 39(11):6291-6297. PubMed ID: 31704859 [TBL] [Abstract][Full Text] [Related]
3. Tumoral FOXP3 expression is associated with favorable clinicopathological variables and good prognosis in gastric adenocarcinoma: the tumor suppressor function of tumoral FOXP3 is related with the P21 expression in gastric adenocarcinoma. Won KY; Kim GY; Kim HK; Choi SI; Kim SH; Bae GE; Lim JU; Lim SJ Hum Pathol; 2017 Oct; 68():112-118. PubMed ID: 28882702 [TBL] [Abstract][Full Text] [Related]
4. Increased expression of DLX2 correlates with advanced stage of gastric adenocarcinoma. Tang P; Huang H; Chang J; Zhao GF; Lu ML; Wang Y World J Gastroenterol; 2013 May; 19(17):2697-703. PubMed ID: 23674878 [TBL] [Abstract][Full Text] [Related]
5. Abnormal expression of pRb, p16, and cyclin D1 in gastric adenocarcinoma and its lymph node metastases: relationship with pathological features and survival. Feakins RM; Nickols CD; Bidd H; Walton SJ Hum Pathol; 2003 Dec; 34(12):1276-82. PubMed ID: 14691913 [TBL] [Abstract][Full Text] [Related]
6. Expression and prognostic roles of the G1-S modulators in hepatocellular carcinoma: p27 independently predicts the recurrence. Ito Y; Matsuura N; Sakon M; Miyoshi E; Noda K; Takeda T; Umeshita K; Nagano H; Nakamori S; Dono K; Tsujimoto M; Nakahara M; Nakao K; Taniguchi N; Monden M Hepatology; 1999 Jul; 30(1):90-9. PubMed ID: 10385644 [TBL] [Abstract][Full Text] [Related]
7. Cell cycle dysregulation influences survival in high risk breast cancer patients. Königsberg R; Rögelsperger O; Jäger W; Thalhammer T; Klimpfinger M; De Santis M; Hudec M; Dittrich C Cancer Invest; 2008 Aug; 26(7):734-40. PubMed ID: 18665474 [TBL] [Abstract][Full Text] [Related]
8. Cyclin E dependent kinase activity in human breast cancer in relation to cyclin E, p27 and p21 expression and retinoblastoma protein phosphorylation. Lodén M; Nielsen NH; Roos G; Emdin SO; Landberg G Oncogene; 1999 Apr; 18(16):2557-66. PubMed ID: 10353599 [TBL] [Abstract][Full Text] [Related]
9. Relationship between expression of IGFBP7 and clinicopathological variables in gastric cancer. Sato Y; Inokuchi M; Takagi Y; Otsuki S; Fujimori Y; Yanaka Y; Kobayashi K; Higuchi K; Kojima K; Kawano T J Clin Pathol; 2015 Oct; 68(10):795-801. PubMed ID: 26043748 [TBL] [Abstract][Full Text] [Related]
10. The prognostic significance of p21 and Her-2 gene expression and mutation/polymorphism in patients with gastric adenocarcinoma. Ozen A; Kocak Z; Sipahi T; Oz-Puyan F; Cakina S; Saynak M; Ibis C; Karagol H Med Oncol; 2013 Mar; 30(1):357. PubMed ID: 23275116 [TBL] [Abstract][Full Text] [Related]
12. Significance of TFF3 protein and Her-2/neu status in patients with gastric adenocarcinoma. Xu CC; Yue L; Wei HJ; Zhao WW; Sui AH; Wang XM; Qiu WS Pathol Res Pract; 2013 Aug; 209(8):479-85. PubMed ID: 23822993 [TBL] [Abstract][Full Text] [Related]
13. Programmed cell death ligand 1 (PD-L1) expression on gastric cancer and its relationship with clinicopathologic factors. Zhang L; Qiu M; Jin Y; Ji J; Li B; Wang X; Yan S; Xu R; Yang D Int J Clin Exp Pathol; 2015; 8(9):11084-91. PubMed ID: 26617827 [TBL] [Abstract][Full Text] [Related]
14. Loss of p16 and p27 is associated with progression of human gastric cancer. Myung N; Kim MR; Chung IP; Kim H; Jang JJ Cancer Lett; 2000 May; 153(1-2):129-36. PubMed ID: 10779641 [TBL] [Abstract][Full Text] [Related]
15. Expression of the cell cycle proteins p21, p27, and pRb in clear cell renal cell carcinoma and their prognostic significance. Haitel A; Wiener HG; Neudert B; Marberger M; Susani M Urology; 2001 Sep; 58(3):477-81. PubMed ID: 11549509 [TBL] [Abstract][Full Text] [Related]
16. Combination of p53 expression and p21 loss has an independent prognostic impact on sporadic colorectal cancer. Noske A; Lipka S; Budczies J; Müller K; Loddenkemper C; Buhr HJ; Kruschewski M Oncol Rep; 2009 Jul; 22(1):3-9. PubMed ID: 19513497 [TBL] [Abstract][Full Text] [Related]
17. Expression of cell cycle regulators p21 and p27 as predictors of disease outcome in colorectal carcinoma. Al-Maghrabi J; Al-Ahwal M; Buhmeida A; Syrjänen K; Sibyani A; Emam E; Ghanim A; Al-Qahtani M J Gastrointest Cancer; 2012 Jun; 43(2):279-87. PubMed ID: 21637966 [TBL] [Abstract][Full Text] [Related]
18. Nuclear overexpression of the overexpressed in lung cancer 1 predicts worse prognosis in gastric adenocarcinoma. Wang J; Shen H; Fu G; Zhao D; Wang W Oncotarget; 2017 Feb; 8(6):9442-9450. PubMed ID: 28038462 [TBL] [Abstract][Full Text] [Related]
19. Protein expression of HER2, 3, 4 in gastric cancer: correlation with clinical features and survival. He XX; Ding L; Lin Y; Shu M; Wen JM; Xue L J Clin Pathol; 2015 May; 68(5):374-80. PubMed ID: 25731189 [TBL] [Abstract][Full Text] [Related]
20. Analysis of phosphorylation of pRB and its regulatory proteins in breast cancer. Wakasugi E; Kobayashi T; Tamaki Y; Nakano Y; Ito Y; Miyashiro I; Komoike Y; Miyazaki M; Takeda T; Monden T; Monden M J Clin Pathol; 1997 May; 50(5):407-12. PubMed ID: 9215124 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]